Human and animal exposure to the SARS-Cov-2 virus via inhaled air
There are many questions surrounding transmission of the virus in the air responsible for Covid-19. The objective of the University of Liège is to study this transmission via inhaled air both in humans and in pets, and to have a better understanding to prevent and protect human and animal health.
|Project Initiator: University of Liège, Research Unit of the Veterinary Medicine Faculty (FARAH)||Year of support: 2020|
|Location: Liège, Belgium||Amount provided: EUR 50,000|
Air transmission and prevention
The current consensus is that the SARS-CoV-2 virus can be transmitted by air. Furthermore, cases of transmission to domestic animals have been reported. Getting a better understanding of the transmission mechanisms is a public health priority. The University of Liège is developing a double quantitative evaluation model for human exposure and animal exposure to the SARS-Cov-2 virus via inhaled air. Its objective is to evaluate risk reduction measures and advise politicians and healthcare professionals about the risks and the means of prevention.
© FMV / Dominique Votion ULIEGE FARAH
The project is divided into 3 phases:
- Development of a quantitative model of human and animal exposure via inhaled air: transmission diagram, mathematic transmission model for quantifying human and animal exposure according to various variables, analysis of sensitivity and exposure scenarios
- Evaluation of exposure risk reduction measures (between humans, between humans and pets)
- Recommendations for reducing air exposure to SARS-Cov-2 of exposed individuals (healthcare professionals, the general public, pet owners)
How the Air Liquide Foundation is participating
The financial support from the Air Liquide Foundation is dedicated to paying the salaries of specialist personnel and to the operational costs of the project.
Discover other projects we support
Study of biomarkers of Covid-19 aggravation
Anticipating treatment of patients before their condition worsensRead more
Identifying diagnostic biomarkers and therapeutic strategies
The VirPath team, at the International Center for Infectiology Research in Lyon, has been working since early 2020 on Covid-19.Read more